Tomoko Ise

2.8k total citations · 1 hit paper
47 papers, 2.3k citations indexed

About

Tomoko Ise is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tomoko Ise has authored 47 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 16 papers in Immunology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tomoko Ise's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Tomoko Ise is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Toxin Mechanisms and Immunotoxins (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Tomoko Ise collaborates with scholars based in Japan, United States and Sweden. Tomoko Ise's co-authors include Hiroto Izumi, Kimitoshi Kohno, Minoru Nomoto, Hidetaka Uramoto, Tadashi Murakami, Satoshi Nagata, Mizuho Tanabe, Yoichiro Yoshida, Takayuki Torigoe and Hiroshi Ishiguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Tomoko Ise

46 papers receiving 2.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy

2003 543 citations Hiroto Izumi, Takayuki Torigoe et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Tomoko Ise	1.5k	489	438	272	213	47	2.3k
Gadisetti V.R. Chandramouli	1.6k 1.0×	718 1.5×	303 0.7×	847 3.1×	80 0.4×	75	3.3k
Jonathan W. Wojtkowiak	2.0k 1.3×	782 1.6×	437 1.0×	1.6k 5.7×	172 0.8×	33	4.0k
Zdravka Medarova	1.7k 1.1×	293 0.6×	347 0.8×	519 1.9×	219 1.0×	86	3.9k
Verónica Estrella	1.4k 0.9×	462 0.9×	279 0.6×	679 2.5×	58 0.3×	28	2.5k
C. Boyer	533 0.3×	375 0.8×	277 0.6×	108 0.4×	130 0.6×	45	1.6k
Joseph Johnson	1.0k 0.7×	390 0.8×	405 0.9×	508 1.9×	45 0.2×	53	2.1k
Dawen Zhao	1.3k 0.8×	581 1.2×	530 1.2×	872 3.2×	74 0.3×	73	3.5k
Ian Robey	980 0.6×	267 0.5×	248 0.6×	920 3.4×	86 0.4×	36	2.1k
Zehong Cao	1.2k 0.8×	342 0.7×	745 1.7×	325 1.2×	40 0.2×	28	2.7k
Angela M. Otto	920 0.6×	356 0.7×	134 0.3×	265 1.0×	166 0.8×	84	2.3k

Countries citing papers authored by Tomoko Ise

Since Specialization

Citations

This map shows the geographic impact of Tomoko Ise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Ise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Ise more than expected).

Fields of papers citing papers by Tomoko Ise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Ise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Ise. The network helps show where Tomoko Ise may publish in the future.

Co-authorship network of co-authors of Tomoko Ise

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Ise. A scholar is included among the top collaborators of Tomoko Ise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Ise. Tomoko Ise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akiba, Hiroki, Tomoko Ise, Yasuhiro Abe, et al.. (2025). Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 molecule. PubMed. 8(1). 56–67.

Furukawa, Kentaro, Tomoko Ise, Masahiro Takayama, et al.. (2024). Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo. PLoS ONE. 19(12). e0300297–e0300297. 2 indexed citations

Akiba, Hiroki, Junso Fujita, Tomoko Ise, et al.. (2023). Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing signaling activity through epitope selection. Communications Biology. 6(1). 987–987. 7 indexed citations

Akiba, Hiroki, Tomoko Ise, Satoshi Nagata, et al.. (2021). Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing. Scientific Reports. 11(1). 19411–19411. 4 indexed citations

Khan, Sheema, Nadeem Zafar, Saini Setua, et al.. (2018). Clinical significance of MUC13 in pancreatic ductal adenocarcinoma. HPB. 20(6). 563–572. 19 indexed citations

Khan, Sheema, Mohammed Sikander, Mara C. Ebeling, et al.. (2016). MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression. Oncogene. 36(4). 491–500. 26 indexed citations

Wysocka, Maria, Andrew V. Kossenkov, Bernice Benoit, et al.. (2013). CD164 and FCRL3 Are Highly Expressed on CD4+CD26 − T Cells in Sézary Syndrome Patients. Journal of Investigative Dermatology. 134(1). 229–236. 31 indexed citations

Das, Sudipto, Tomoko Ise, Satoshi Nagata, et al.. (2007). Palmitoylation of POTE family proteins for plasma membrane targeting. Biochemical and Biophysical Research Communications. 363(3). 751–756. 7 indexed citations

Ise, Tomoko, Sudipto Das, Satoshi Nagata, et al.. (2007). Expression of POTE protein in human testis detected by novel monoclonal antibodies. Biochemical and Biophysical Research Communications. 365(4). 603–608. 14 indexed citations

10.

Shimizu, Takahiro, et al.. (2006). Impaired activity of volume‐sensitive Cl⁻ channel is involved in cisplatin resistance of cancer cells. Journal of Cellular Physiology. 211(2). 513–521. 74 indexed citations

11.

Ise, Tomoko, Satoshi Nagata, Robert J. Kreitman, et al.. (2006). Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma. Leukemia. 21(1). 169–174. 50 indexed citations

12.

Ise, Tomoko, et al.. (2005). Roles of Volume-sensitive Cl− Channel in Cisplatin-induced Apoptosis in Human Epidermoid Cancer Cells. The Journal of Membrane Biology. 205(3). 139–145. 51 indexed citations

13.

Izumi, Hiroto, Tomoko Ise, Tadashi Murakami, et al.. (2003). Structural and functional characterization of two human V-ATPase subunit gene promoters. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1628(2). 97–104. 10 indexed citations

14.

Torigoe, Takayuki, Hiroto Izumi, Hiroshi Ishiguchi, et al.. (2002). Enhanced Expression of the Human Vacuolar H+-ATPase c subunit Gene (ATP6L) in Response to Anticancer Agents. Journal of Biological Chemistry. 277(39). 36534–36543. 71 indexed citations

15.

Uramoto, Hidetaka, Hiroto Izumi, Tomoko Ise, et al.. (2002). p73 Interacts with c-Myc to Regulate Y-box-binding Protein-1 Expression. Journal of Biological Chemistry. 277(35). 31694–31702. 81 indexed citations

16.

Torigoe, Takayuki, Hiroto Izumi, Tomoko Ise, et al.. (2002). Vacuolar H+-ATPase: functional mechanisms and potential as a target for cancer chemotherapy. Anti-Cancer Drugs. 13(3). 237–243. 46 indexed citations

17.

Imamura, Toshihiro, Hiroto Izumi, Gunji Nagatani, et al.. (2001). Interaction with p53 Enhances Binding of Cisplatin-modified DNA by High Mobility Group 1 Protein. Journal of Biological Chemistry. 276(10). 7534–7540. 84 indexed citations

18.

Murakami, Tadashi, Izumi Shibuya, Tomoko Ise, et al.. (2001). Elevated expression of vacuolar proton pump genes and cellular ph in cisplatin resistance. International Journal of Cancer. 93(6). 869–874. 125 indexed citations

19.

Ise, Tomoko, Hiroto Izumi, Gunji Nagatani, et al.. (1999). Structural Characterization of the Human Interleukin-13 Receptor α1 Gene Promoter. Biochemical and Biophysical Research Communications. 265(2). 387–394. 7 indexed citations

20.

Hatano, Yutaka, Kazumoto Katagiri, Tomoko Ise, et al.. (1999). Expression of Th1 and Th2 cytokine mRNAs in freshly isolated peripheral blood mononuclear cells of a patient with cutaneous paragonimiasis. Journal of Dermatological Science. 19(2). 144–147. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact